|
Index of reports
> Cases resulting in death (93)
Below is the selection of adverse event reports related to Taxol (Paclitaxel) that includes cases resulting in death.
Reports 1 - 25 of 93 Next >>
Adverse event in 41 year old male receiving Taxol (Paclitaxel)
Reported by a physician from Japan on 2007-10-30
Patient: 41 year old male
Adverse reactions / side effects: Pancytopenia, Renal Failure Acute
Adverse event resulted in: death
Suspect drug(s):
Taxol
Indication: Lung Adenocarcinoma
Start date: 2007-10-03
End date: 2007-10-03
Paraplatin
Indication: Lung Adenocarcinoma
Start date: 2007-10-03
End date: 2007-10-03
Adverse event in male receiving Taxol (Paclitaxel)
Reported by a individual with unspecified qualification from United States on 2007-10-26
Patient: male, weighing 74.3 kg (163.5 pounds)
Adverse reactions / side effects: Pneumothorax, Pyrexia, Respiratory Distress, Lung Abscess
Adverse event resulted in: death, hospitalization
Suspect drug(s):
Carboplatin
Dosage: 6 mg
Taxol
Dosage: 200 mg
Other drugs received by patient: Albuterol; Calcium; Ertapenem; Heparin; Hydrocodone Bitartrate; Ipratropium Bromide; Mirtazapine; Omeprazole; Oxycodone HCL; Senna; Vitamin D; Voriconazole
Adverse event in 61 year old female receiving Taxol (Paclitaxel)
Reported by a physician from France on 2007-10-24
Patient: 61 year old female
Adverse reactions / side effects: Hepatitis Fulminant
Adverse event resulted in: death
Suspect drug(s):
Taxol
Start date: 2007-10-11
Carboplatin
Taxotere
Avastin
Start date: 2007-10-11
Solu-Medrol
Start date: 2007-10-11
Arimidex
Administration route: Oral
Start date: 2007-10-11
Adverse event in 41 year old male receiving Taxol (Paclitaxel)
Reported by a physician from Japan on 2007-10-22
Patient: 41 year old male
Adverse reactions / side effects: Renal Failure Acute
Adverse event resulted in: death
Suspect drug(s):
Taxol
Indication: non-Small Cell Lung Cancer
Start date: 2007-10-03
End date: 2007-10-03
Paraplatin
Indication: non-Small Cell Lung Cancer
Start date: 2007-10-03
End date: 2007-10-03
Adverse event in 74 year old male receiving Taxol (Paclitaxel)
Reported by a physician from Japan on 2007-10-18
Patient: 74 year old male
Adverse reactions / side effects: Interstitial Lung Disease
Adverse event resulted in: death
Suspect drug(s):
Taxol
Dosage: started on 20-aug-2007.
Indication: Gastric Cancer
Start date: 2007-08-27
End date: 2007-08-27
TS-1
Administration route: Oral
Indication: Gastric Cancer
Start date: 2007-08-20
End date: 2007-09-03
Other drugs received by patient: Famotidine; Decadron; Kytril; Predonine; Lansoprazole; Cleanal; Warfarin Potassium; Novolin R
Adverse event in male receiving Taxol (Paclitaxel)
Reported by a physician from United Kingdom on 2007-10-16
Patient: male
Adverse reactions / side effects: Thrombosis, Sudden Death
Adverse event resulted in: death, life threatening event
Suspect drug(s):
Bevacizumab
Dosage: 15 mg/kg, q3w
Indication: non-Small Cell Lung Cancer
Start date: 2007-06-13
End date: 2007-08-28
Cetuximab
Dosage: 250 mg/m2, 1/week
Indication: non-Small Cell Lung Cancer
Start date: 2007-06-13
End date: 2007-08-28
Cetuximab
Dosage: 400 mg/m2, unk
Taxol
Dosage: 200 mg/m2, q3w
Indication: non-Small Cell Lung Cancer
Start date: 2007-06-13
End date: 2007-08-28
Carboplatin
Dosage: 6 auc, q3w
Indication: non-Small Cell Lung Cancer
Start date: 2007-06-13
End date: 2007-08-28
Adverse event in 65 year old male receiving Taxol (Paclitaxel)
Reported by a consumer/non-health professional from Japan on 2007-10-11
Patient: 65 year old male
Adverse reactions / side effects: Pain in Extremity, Disease Progression, Haemoglobin Decreased, Cyanosis, Respiratory Failure, Depressed Level of Consciousness, Neutrophil Count Decreased, Renal Failure Acute
Adverse event resulted in: death, life threatening event
Suspect drug(s):
Ifomide
Dosage: 1.3g iv 19-jul-2005 and continued
Indication: Prostate Cancer
Start date: 2005-06-21
Taxol
Dosage: 21-jun-2005 to 21-jun-2005; 19-jul-2005 to 19-jul-2005.
Indication: Prostate Cancer
Start date: 2005-06-21
End date: 2005-07-19
Aqupla
Dosage: 50mg iv on 19-jul-2005
Indication: Prostate Cancer
Start date: 2005-06-21
End date: 2005-07-19
Loxonin
Dosage: 20-jul-2005 to 28-jul-2005 and 27-jun-2005 to 29-jun-2005.
Administration route: Oral
Indication: Pain in Extremity
Start date: 2005-06-27
End date: 2005-07-28
Other drugs received by patient: Methotrexate; Doxorubicin HCL; Cisplatin; Vinblastine Sulfate; Cytotec
Adverse event in male receiving Taxol (Paclitaxel)
Reported by a individual with unspecified qualification from United States on 2007-10-09
Patient: male, weighing 74.3 kg (163.5 pounds)
Adverse reactions / side effects: Pneumothorax, Lung Abscess
Adverse event resulted in: death, hospitalization
Suspect drug(s):
Carboplatin
Dosage: 6 mg
Taxol
Dosage: 200 mg
Other drugs received by patient: Albuterol; Calcium; Ertapenem; Heparin; Hydrocodone; Ipratropium Bromide; Mirtazapine; Omeprazole; Oxycodone HCL; Senna; Vitamin D; Voriconazole
Adverse event in 52 year old male receiving Taxol (Paclitaxel)
Reported by a individual with unspecified qualification from Japan on 2007-10-09
Patient: 52 year old male
Adverse reactions / side effects: Pco2 Decreased, Dyspnoea, Body Temperature Increased, Computerised Tomogram Abnormal, Chest X-RAY Abnormal, PO2 Decreased, Cardio-Respiratory Arrest, Heart Rate Decreased, Interstitial Lung Disease, C-Reactive Protein Increased, Cell Marker Increased, White Blood Cell Count Increased, Oxygen Saturation Decreased, Panic Reaction
Adverse event resulted in: death
Suspect drug(s):
Zometa
Dosage: 4 mg, once/single
Indication: Metastases TO Bone
Start date: 2006-07-26
End date: 2006-07-26
Zometa
Dosage: 4 mg, once/single
Start date: 2006-09-15
End date: 2006-09-15
Paraplatin
Dosage: 600 mg/day
Indication: Lung Neoplasm Malignant
Start date: 2006-04-03
End date: 2006-08-09
Taxol
Dosage: 120 mg/day
Indication: Lung Neoplasm Malignant
Start date: 2006-04-03
End date: 2006-08-09
Meropen
Dosage: 1 g/day
Indication: Pneumonia
Start date: 2005-09-05
End date: 2005-09-15
Other drugs received by patient: Durotep Janssen; Opso Dainippon; Clonazepam; Cerocral; Lansoprazole; Lorazepam; Rhythmy; Voltaren; Mucosta; Urso 250; Carboplatin
Adverse event in female receiving Taxol (Paclitaxel)
Reported by a physician from France on 2007-10-09
Patient: female
Adverse reactions / side effects: Metastases TO Nervous System, Breast Cancer, Cognitive Disorder
Adverse event resulted in: death
Suspect drug(s):
Taxol (Paclitaxel)
Adverse event in 55 year old female receiving Taxol (Paclitaxel)
Reported by a consumer/non-health professional from Singapore on 2007-10-05
Patient: 55 year old female
Adverse reactions / side effects: Myocardial Infarction
Adverse event resulted in: death
Suspect drug(s):
Taxol (Paclitaxel)
Adverse event in 74 year old male receiving Taxol (Paclitaxel)
Reported by a physician from Japan on 2007-10-03
Patient: 74 year old male
Adverse reactions / side effects: Interstitial Lung Disease
Adverse event resulted in: death
Suspect drug(s):
Taxol
Indication: Gastric Cancer
Start date: 2007-08-27
End date: 2007-08-27
Tegafur + Gimeracil + Oteracil Potassium
Administration route: Oral
Indication: Gastric Cancer
Start date: 2007-08-20
End date: 2007-09-02
Adverse event in 52 year old male receiving Taxol (Paclitaxel)
Reported by a individual with unspecified qualification from Japan on 2007-10-02
Patient: 52 year old male
Adverse reactions / side effects: Pco2 Decreased, Dyspnoea, Body Temperature Increased, PO2 Decreased, Heart Rate Decreased, Cardio-Respiratory Arrest, C-Reactive Protein Increased, Interstitial Lung Disease, Cell Marker Increased, White Blood Cell Count Increased, Panic Reaction, Oxygen Saturation Decreased
Adverse event resulted in: death
Suspect drug(s):
Zometa
Dosage: 4 mg, once/single
Indication: Metastases TO Bone
Start date: 2006-07-26
End date: 2006-07-26
Zometa
Dosage: 4 mg, once/single
Start date: 2006-09-15
End date: 2006-09-15
Paraplatin
Dosage: 600 mg/day
Indication: Lung Neoplasm Malignant
Start date: 2006-04-03
End date: 2006-08-09
Taxol
Dosage: 120 mg/day
Indication: Lung Neoplasm Malignant
Start date: 2006-04-03
End date: 2006-08-09
Meropen
Dosage: 1 g/day
Indication: Pneumonia
Start date: 2005-09-05
End date: 2005-09-15
Other drugs received by patient: Durotep Janssen; Opso Dainippon; Clonazepam; Cerocral; Lansoprazole; Lorazepam; Rhythmy; Voltaren; Mucosta; Urso 250
Adverse event in 66 year old male receiving Taxol (Paclitaxel)
Reported by a health professional (non-physician/pharmacist) from Japan on 2007-10-01
Patient: 66 year old male
Adverse reactions / side effects: Malaise, Malignant Neoplasm Progression, Anaemia, Febrile Neutropenia, Acute Respiratory Distress Syndrome
Adverse event resulted in: death, life threatening event, hospitalization
Suspect drug(s):
Taxol (Paclitaxel)
Other drugs received by patient: TS-1; Fluconazole
Adverse event in 70 year old female receiving Taxol (Paclitaxel)
Reported by a health professional (non-physician/pharmacist) from Japan on 2007-07-31
Patient: 70 year old female
Adverse reactions / side effects: Cerebral Infarction
Adverse event resulted in: death
Suspect drug(s):
Taxol
Indication: non-Small Cell Lung Cancer
Paraplatin
Indication: non-Small Cell Lung Cancer
Adverse event in female receiving Taxol (Paclitaxel)
Reported by a physician from United States on 2007-07-25
Patient: female, weighing 60.8 kg (133.7 pounds)
Adverse reactions / side effects: Sepsis
Adverse event resulted in: death
Suspect drug(s):
Bevacizumab
Dosage: 913 mg, q3w
Indication: non-Small Cell Lung Cancer
Start date: 2007-05-25
Carboplatin
Dosage: 455 mg, q3w
Indication: non-Small Cell Lung Cancer
Start date: 2007-05-25
Taxol
Dosage: 280 mg, q3w
Indication: non-Small Cell Lung Cancer
Start date: 2007-05-25
Adverse event in female receiving Taxol (Paclitaxel)
Reported by a physician from United States on 2007-07-23
Patient: female, weighing 75.7 kg (166.6 pounds)
Adverse reactions / side effects: Blood Bicarbonate Increased
Adverse event resulted in: death
Suspect drug(s):
Bevacizumab
Dosage: 762 mg, unk
Indication: Small Cell Lung Cancer Stage Unspecified
Start date: 2007-06-13
Taxol
Dosage: 90 mg/m2, days 1+15
Indication: Small Cell Lung Cancer Stage Unspecified
Start date: 2007-06-13
Other drugs received by patient: Arimidex
Adverse event in female receiving Taxol (Paclitaxel)
Reported by a physician from United States on 2007-07-20
Patient: female, weighing 60.8 kg (133.7 pounds)
Adverse reactions / side effects: Sepsis, Dehydration
Adverse event resulted in: death
Suspect drug(s):
Bevacizumab
Dosage: 913 mg, q3w
Indication: non-Small Cell Lung Cancer
Start date: 2007-05-25
Carboplatin
Dosage: 455 mg, q3w
Indication: non-Small Cell Lung Cancer
Start date: 2007-05-25
Taxol
Dosage: 280 mg, q3w
Indication: non-Small Cell Lung Cancer
Start date: 2007-05-25
Adverse event in 75 year old female receiving Taxol (Paclitaxel)
Reported by a consumer/non-health professional from United Kingdom on 2007-07-17
Patient: 75 year old female
Adverse reactions / side effects: Acute Leukaemia
Adverse event resulted in: death, hospitalization
Suspect drug(s):
Herceptin
Dosage: 9 mg/kg, unk
Indication: Breast Cancer
Start date: 2005-09-05
End date: 2006-08-08
Taxol
Dosage: 80 mg/m2, unk
Indication: Breast Cancer
Start date: 2005-09-05
End date: 2006-01-09
Hydrea
Administration route: Oral
Indication: Thrombocytopenia
Start date: 1995-06-15
End date: 1999-11-30
Other drugs received by patient: Carboplatin; Arimidex; Anagrelide HCL; Vercyte
Adverse event in 85 year old female receiving Taxol (Paclitaxel)
Reported by a health professional (non-physician/pharmacist) from Japan on 2007-07-09
Patient: 85 year old female
Adverse reactions / side effects: Interstitial Lung Disease
Adverse event resulted in: death
Suspect drug(s):
Taxol
Indication: Ovarian Cancer
Start date: 2005-11-01
Paraplatin
Indication: Ovarian Cancer
Start date: 2005-11-01
Adverse event in female receiving Taxol (Paclitaxel)
Reported by a physician from United States on 2007-07-06
Patient: female, weighing 75.7 kg (166.6 pounds)
Adverse reactions / side effects: Blood Bicarbonate Increased
Adverse event resulted in: death
Suspect drug(s):
Bevacizumab
Dosage: 762 mg, unk
Indication: Small Cell Lung Cancer Stage Unspecified
Start date: 2007-06-13
Taxol
Dosage: 90 mg/m2, days 1+15
Indication: Small Cell Lung Cancer Stage Unspecified
Start date: 2007-06-13
Adverse event in 72 year old male receiving Taxol (Paclitaxel)
Reported by a consumer/non-health professional from United States on 2007-07-05
Patient: 72 year old male
Adverse reactions / side effects: Renal Failure, Respiratory Failure, Malignant Neoplasm Progression
Adverse event resulted in: death, hospitalization
Suspect drug(s):
Erbitux
Indication: non-Small Cell Lung Cancer
Start date: 2006-11-06
End date: 2006-11-06
Carboplatin
Indication: non-Small Cell Lung Cancer
Start date: 2006-10-20
End date: 2006-10-20
Taxol
Indication: non-Small Cell Lung Cancer
Start date: 2006-11-13
End date: 2006-11-13
Other drugs received by patient: Prednisone TAB; Singulair; Norco; Felodipine; Zocor
Adverse event in 62 year old male receiving Taxol (Paclitaxel)
Reported by a health professional (non-physician/pharmacist) from Japan on 2007-06-28
Patient: 62 year old male
Adverse reactions / side effects: Bronchopulmonary Aspergillosis
Adverse event resulted in: death
Suspect drug(s):
Taxol
Indication: Gastric Cancer
Briplatin
Indication: Gastric Cancer
Adverse event in 66 year old female receiving Taxol (Paclitaxel)
Reported by a physician from Japan on 2007-06-22
Patient: 66 year old female
Adverse reactions / side effects: Pneumonia, Sepsis, Pancytopenia
Adverse event resulted in: death, hospitalization
Suspect drug(s):
Paraplatin
Indication: Uterine Cancer
Start date: 2007-06-01
End date: 2007-06-01
Taxol
Indication: Uterine Cancer
Start date: 2007-06-01
End date: 2007-06-01
Other drugs received by patient: Gaster; Kytril; Dexart; Flomoxef Sodium; Diclofenac Sodium; Restamin; Actos; Daonil; Amlodin; Almarl; Dogmatyl
Adverse event in 72 year old male receiving Taxol (Paclitaxel)
Reported by a consumer/non-health professional from United States on 2007-06-22
Patient: 72 year old male
Adverse reactions / side effects: Renal Failure, Pneumonia, Respiratory Failure, Sepsis, Malignant Neoplasm Progression
Adverse event resulted in: death, hospitalization
Suspect drug(s):
Erbitux
Indication: non-Small Cell Lung Cancer
Start date: 2006-11-06
End date: 2006-11-06
Carboplatin
Indication: non-Small Cell Lung Cancer
Start date: 2006-10-20
End date: 2006-10-20
Taxol
Indication: non-Small Cell Lung Cancer
Start date: 2006-11-13
End date: 2006-11-13
Other drugs received by patient: Prednisone TAB; Singulair; Norco; Felodipine; Zocor
Page 1 Next >>
|
